Home › Medical Devices
Medical Devices Market Research Reports & Consulting
Market Reports
| Title | Published | Price | TOC Available |
|---|---|---|---|
Pharmaceutical Robots Market by Type (Traditional Robots (Articulated Robots, SCARA Robots, Delta Robots, Cartesian Robots), Collaborative Robots), Application (Picking and Packaging, Laboratory Applications) - Global Forecast to 2021This report studies the global pharmaceutical robots market for the forecast period of 2016 to 2021. This market is expected to reach USD 119.5 Million by 2021 from USD 64.4 Million in 2016, at a CAGR of 13.2% during the forecast period. The key factor driving the growth of the market is the benefits offered by robotic systems in pharmaceutical manufacturing. |
April 2017 | $ 5650 |
|
Active Implantable Medical Devices Market by Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable Hearing Devices) - Global Forecast to 2022The active implantable medical devices market is expected to witness significant growth in the coming years. The growing aging population, increasing prevalence of cardiovascular and neurological diseases, investments and funds to develop technologically advanced products, expanded applications of neurostimulators, and favorable reimbursement scenario for ENT procedures in developed countries are some of the factors driving the growth of this market. The implantable and life-sustaining devices market is projected to reach USD 26.75 Billion by 2022 from 18.42 Billion in 2017, at a CAGR of 7.8% from 2017 to 2022. |
April 2017 | $ 5650 |
|
Intraoperative Imaging Market by Product (Mobile C-arms, CT, Intraoperative MRI, Intraoperative Ultrasound), Application (Neurosurgery, Orthopedic, Trauma, Spine Surgery, Cardiovascular, ENT, Gastro, Maxillofacial Surgery) & End User (Hospitals, ASC, Clinic) - Global Forecast to 2021The global Intraoperative Imaging market is projected to reach USD 2.06 Billion by 2021 from USD 1.61 Billion in 2016, at a CAGR of 5.2% during the forecast period of 2016 to 2021. A number of factors, such as the growth in the aging population, rising burden of chronic diseases with changing lifestyles, increasing preference and demand for minimally invasive surgeries (MIS), and expanding applications of neurosurgery and orthopedic surgery are expected to fuel the growth of the intraoperative imaging market. |
March 2017 | $ 5650 |
|
Dental Syringes Market by Product (Non-disposable Syringes, Disposable Syringes and Safety Syringes), Type (Aspirating & Non-aspirating), Material (Plastic and Metallic), Region (North America, Europe , Asia-Pacific, and RoW) - Forecast to 2021The global dental syringes market is projected to reach USD 126.9 Million by 2021 from USD 98.5 Million in 2016; growing at a CAGR of 5.2% during 2016-2021. The rising demand for dental syringes can be attributed to the growing technological advancements and growth in geriatric population. |
March 2017 | $ 5650 |
|
Rehabilitation Equipment Market by Type (Mobility (Wheelchair, Assist Device), Body Support (Lift, Sling), Exercise (Upper, Lower Body), Living Aids (Reading, Writing)), Application (Physiotherapy, OT), End User (Hospital, Clinic, Home Care) - Forecasts to 2021The global rehabilitation equipment market is projected to reach USD 14.91 Billion by 2021 from USD 9.86 Billion in 2016, at a CAGR of 8.6% during the forecast period. The market is mainly driven by factors such increasing incidence of disabilities, favorable healthcare reforms, and rapid growth in the geriatric population. |
March 2017 | $ 5650 |
|
Medical Supplies Market by Type (Diagnostic, Dialysis, Wound Care, Inhalation, Infection Control, Infusion, Intubation, PPE), Application (Anesthesia, Radiology, Sterilization) & End User (Hospital, Clinic, Nursing Home) - Global Forecast to 2021The medical supplies market is projected to reach USD 136.63 Billion by 2021 from USD 98.33 Billion in 2016, at a CAGR of 6.8% during the forecast period. Medical supplies include single-use or disposable products used in all healthcare facilities such as hospitals, clinics, and nursing homes. They are categorized based on their applications and usage in healthcare facilities. |
March 2017 | $ 5650 |
|
Medical Radiation Detection, Monitoring & Safety Market by Detection Type (Gas-Filled Detectors, Geiger Muller, Survey Meter, Solid-State), Products (Personal Dosimeters, OSL, Badges), Safety (Apron, Shields, Face Mask, Gloves), End User - Forecast to 2021The global medical radiation detection, monitoring, and safety market is expected to reach USD 1,215.4 Million by 2021 from USD 887.0 Million in 2016, at a CAGR of 6.5% from 2016 to 2021. This market is segmented based on detectors, detection and monitoring products, safety products, end users, and regions. Growth in the medical radiation detection and monitoring market is mainly driven by factors such as increasing usage of nuclear medicine and radiation therapy for diagnosis and treatment, growing worldwide prevalence of cancer, increasing safety awareness among people working in radiation-prone environments, and the growing number of people covered by insurance. |
March 2017 | $ 5650 |
|
Topical Drug Delivery Market by Product Type (Formulation (Solid, Cream, Lotion, Paste, Liquid), Transdermal (Patch, Gel)), Route of Administration (Skin, Ophthalmic, Rectal, Vaginal, Nasal), & Facility of Use (Hospital, Clinic, Home care, Research) - Global Forecast to 2021The topical drug delivery market is expected to reach USD 125.88 Billion by 2021 from USD 92.40 Billion in 2016 at a CAGR of 6.4% during the forecast period. Major factors driving the growth of this market are the high incidence of burn injuries, rising geriatric population, and increasing incidence of diabetes. However, the negative impact of product recalls may restrain the growth of this market in the coming years. |
March 2017 | $ 5650 |
|
Anatomic Pathology Market by Product & Service (Instruments (Tissue Processing Systems, Microtome), Consumables (Reagent & Antibodies), Histopathology, Cytopathology), Application (Disease Diagnosis, Drug Discovery & Development) - Forecasts to 2021The anatomic pathology market was valued at USD 16.2 Billion in 2016 and poised to grow at a CAGR of 6.1% between 2016 and 2021, to reach USD 21.9 Billion in 2021. Key players operating in the anatomic pathology market include F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Sakura Finetechnical Co., Ltd. (Japan), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), and NeoGenomics Laboratories, Inc. (U.S.). |
March 2017 | $ 5650 |
|
Geomembranes Market by Raw Material (HDPE, LDPE & LLDPE, PVC, EPDM, PP), Manufacturing Process (Blown Film, Calendering), Application (Waste Management, Mining, Water Management, Tunnel Lining), Region - Global Forecast to 2021The global geomembranes market is projected to reach USD 3.41 Billion by 2021 at a CAGR of 9.2% from 2016 to 2021. The geomembranes market has witnessed high growth in the recent years. Geomembranes, due to their functionalities, such as excellent chemical resistance, ability to withstand an elevated temperature range, low permeability, weatherability, UV resistance, and high tear and puncture resistance, are used in a wide range of applications, including waste management, mining, and others. |
March 2017 | $ 5650 |
|
Blood Flow Measurement Devices Market by Product (Ultrasound (Transit Time Flow Meter), Laser Doppler), Application (Invasive (CABG, Microvascular Surgery), Non-invasive (Cardiovascular, Gastroenterology & Tumor Monitoring)) - Global Forecast to 2021The blood flow measurement devices market is projected to reach USD 533.0 Million by 2021 from USD 343.6 Million in 2016, growing at a CAGR of 9.2% in the next five years (2016 to 2021). The growth of the overall blood flow measurement devices market can be contributed to the growing prevalence of cardiovascular diseases and diabetes coupled with rising geriatric population, technological advancements, and the influx of VC funding. |
March 2017 | $ 5650 |
|
Venipuncture Procedure Analysis – By Success Rate (Total Venipuncture, Successful Venipuncture), Vein Type (Cephalic Vein, Median Cubital Vein, Basilic Vein), End Users (Hospitals (Private), Diagnostic Labs, Physicians Offices) - Global Forecast to 2021Venipuncture needle and syringes market is projected to reach USD 1,044.6 Million by 2021 from USD 790.8 Million in 2016, at a CAGR of 5.7% during the forecast period. The U.S. total venipuncture procedure volume contributed the largest share in 2016 and poised to grow at a CAGR of 1.8%. Factors such as aging population, cardiovascular disease death rate, pediatric population, chronic diseases conditions will make venipuncture difficult. |
March 2017 | $ 7150 |
|
Coronary Stent Market by Type (BMS, BVS, Drug Eluting), Mode of Delivery (Self, Balloon Expandable), Material (Metal (Stainless Steel, CoCr, PtCr, Nitinol), Polymer, Copolymer), & End User (Hospital, Cardiology Center, ASC) - Global Forecasts to 2021The coronary stent market is expected to reach USD 10.31 Billion by 2021 from USD 7.16 Billion in 2016, at a CAGR of 7.6% from 2016 to 2021. Major factors driving the growth of this market include technological advancements, increasing number of percutaneous coronary intervention (PCI) procedures, rising burden of CAD, increasing demand for minimally invasive procedures, and rising geriatric population. |
March 2017 | $ 5650 |
|
HIV Diagnosis Market by Test Type (Antibody (ELISA, Rapid, Western Blot), Viral Load, CD4 Count, Early Infant, Viral Identification, Product (Assay, Kit, Reagent, Instrument, Software, Services), End User (Hospitals) - Global Forecast to 2021The HIV diagnosis market is projected to reach USD 3.88 Billion by 2021 from USD 2.35 Billion in 2016, at a CAGR of 10.5% from 2016 to 2021. Factors such as the growing worldwide prevalence of HIV/AIDS, increasing number of blood transfusions and blood donations, benefits offered by point-of-care instruments and kits, and increasing government initiatives are expected to drive the growth of the HIV diagnosis market worldwide. |
March 2017 | $ 5650 |
|
Brain Monitoring Market by Product (MRI, CT, PET, EEG, EMG, MEG, TCD, ICP, Electrodes, Sensors, Gels, Cables), Procedure (Invasive, Non-Invasive), Disease (TBI, Stroke, Dementia, Epilepsy) & End User (Hospital, Clinic, ASC, Ambulance) - Forecasts to 2021The global brain monitoring market is expected to reach USD 12.22 Billion by 2021 from USD 8.80 Billion in 2016, growing at a CAGR of 6.8% from 2016 to 2021. The increasing incidence of neurological disorders, rising awareness about neurodegenerative diseases, growth in the number of traumatic brain injuries, and technological advancements are major factors driving the demand for brain monitoring devices. On the other hand, the shortage of trained professionals to effectively operate brain monitoring devices and unfavorable reimbursement policies are restraining the growth of this market. |
March 2017 | $ 5650 |
|
Interventional Radiology Imaging Market by Product (MRI System, Ultrasound Imaging System, CT Scanner, Angiography System), Procedures (Angiography, Angioplasty, Biopsy) & Application (Cardiology, Oncology, Urology & Nephrology) - Global Forecast to 2021The market is expected to reach USD 23.50 Billion by 2021 from USD 16.99 Billion in 2016, at a CAGR of 6.7%. This market is segmented based on product, procedure, and application. A number of factors, such as rising incidence and prevalence of chronic diseases, increasing demand for minimally invasive procedures, technological advancements are expected to drive the growth of this market. |
March 2017 | $ 5650 |
|
Surgical Sealants and Adhesives Market by Product (Natural & Synthetic, Fibrin, Collagen, Gelatin, Cyanoacrylate, Albumin, Human blood), Indication (Hemostasis, Tissue Sealing), Application (CNS, Cardiovascular, Cosmetic Surgery) - Global Forecast to 2021The global surgical sealants and adhesives market is estimated to grow at a CAGR of 9.6% from 2016 to 2021 to reach USD 2.96 Billion by 2021. The majority of the demand for surgical sealants and adhesives is driven by the growing prevalence and incidence of various disorders such as obesity and CVDs, increasing incidence of trauma, growth in the number of accidents, rising need to manage blood loss in patients, growth in the number of surgeries, and rising geriatric population. In addition, the greater uptake of technologically advanced products and growing adoption of surgical sealants and adhesives in the U.S. and Europe (owing to FDA and CE Mark approvals) are responsible for driving the overall growth of this market. |
February 2017 | $ 5650 |
|
Neurovascular Devices/Interventional Neurology Market by Product (Embolic Coils, Stents, Neurothrombectomy Devices, Microcatheters, Balloon Occlusion Devices, Flow Diversion Devices, Clot Retrievers), Pathology (Aneurysm, AVM) - Global Forecasts to 2021The global neurovascular devices/interventional neurology market is estimated to reach USD 2.62 Billion by 2021, at a CAGR of 8.6% during the forecast period. The large patient population base with target diseases, ongoing product development & commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across emerging markets, and growing market demand for effective neurovascular devices are some key factors driving the growth of the market. |
February 2017 | $ 5650 |
|
Extracorporeal Membrane Oxygenation Machine Market by Modality (Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV)), Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (ECPR)), and Region - Analysis & Forecasts to 2021The global extracorporeal membrane oxygenation (ECMO) machine market is expected to reach USD 305.3 Million by 2021 from USD 247.2 Million in 2016, at a CAGR of 4.3%. The global market is segmented on the basis of modality, application, and region. By modality, the market is segmented into venoarterial (VA), venovenous (VV), and arteriovenous (AV). The venovenous (VV) segment is accounted for the largest share of the market in 2016. The large share of this segment is mainly attributed to the high incidence of respiratory failure, rising lung transplants, increasing incidence of COPD, and technological advancements. The arteriovenous (AV) segment is projected to grow at the highest CAGR in the forecast period. |
February 2017 | $ 5650 |
|
Hemodialysis and Peritoneal Dialysis Market by Products (Machines, Dialyzer, AV Fistula, AV Graft, Bloodlines, Catheters, Transfer Sets, CAPD, APD) & Services, Modality (Conventional, Nocturnal), End User (In-center, Hospital, Home) - Global Forecast to 2021The global hemodialysis and peritoneal dialysis market is estimated to reach 83.89 Billion by 2021, at a CAGR of 6.0% from 2016 to 2021. The growth in this market is driven by the increasing number of ESRD patients, growing prevalence of diabetes & hypertension (major causes of kidney failure), rapid growth in the aging population, preference for dialysis treatments over kidney transplants due to lack of donors, and initiatives taken by leading players to introduce advanced products & services. However, product recalls and the risks & complications associated with dialysis are restricting the growth of this market to a certain extent. Moreover, high competition among market players, high procedural cost, and low cost of kidney transplantation are the foremost challenges faced by industry players. |
February 2017 | $ 5650 |
|
Ablation Technology Market by Product (Radiofrequency, Ultrasound (ESWL, HIFU), Laser, Electrical (Argon Plasma, IRE), Cryotherapy, Microwave, Hydrothermal) & Application (Cardiovascular, Cancer, Pain Management, Orthopedics) - Global Forecasts to 2021The global ablation technology market is estimated to be valued at USD 2.82 Billion in 2016, growing at a CAGR of 10.9% between 2016 and 2021 and reach USD 4.73 Billion. On the basis of type, the market is categorized into laser/light, radiofrequency, ultrasound, electrical, cryoablation, microwave, and hydrothermal ablation technology. The radiofrequency ablation segment is estimated to command the largest share of the global market in 2016 due to lower cost of radiofrequency ablation procedures as compared to other ablation techniques coupled with its high safety, efficacy, and short procedural duration for the treatment of cancer, atrial fibrillation, and pain management. |
February 2017 | $ 5650 |
|
Diagnostic Imaging Market Size & Share by Product (X-ray Imaging (Digital, Analog), MRI (Closed, Open), Ultrasound, CT, Nuclear Imaging (SPECT, Hybrid PET)), Application (OB/GYN, MSK, Cardiology, Oncology), End User (Hospitals, Imaging Centers) - Global Forecast to 2021The overall market for diagnostic imaging is expected to reach $36.43 billion by 2021 from $26.53 billion in 2016, at a CAGR of 6.6%. Factors such as increasing incidence and prevalence of chronic diseases across the globe, technological advancements in the imaging systems, growing government investments for modernization of imaging facilities, and the rising number of diagnostic imaging centers are driving the market growth of diagnostic imaging. However, the high cost of diagnostic imaging systems, technological limitations associated with standalone systems, unfavorable healthcare reforms in the U.S., and shortage of helium are the key factors limiting the growth of this market. |
February 2017 | $ 5650 |
|
Gynecology Surgical Instrument Market by Product (Scissors, Forceps, Trocar, SIMS, CUSCO), Application (Laparoscopy, Colposcopy, Hysteroscopy, D&C, Ablation, Biopsy), & End User (Hospital, Clinic, Ambulatory Surgery Center) - Global Forecast to 2021The gynecology surgical instrument market is expected to reach USD 2.44 Billion by 2021 from USD 1.73 Billion in 2016, at a CAGR of 7.1% from 2016 to 2021. The market is mainly driven by factors such as high incidence of gynecological diseases, increasing awareness programs, and rising government investments for providing advanced healthcare facilities & services, increasing disposable income in developing countries, and rising incidence of lifestyle disorders. |
February 2017 | $ 5650 |
|
Apheresis Market by Product (Plasma & Component Separator, Hemoperfusion, Disposable), Procedure (Therapeutic, Photopheresis, Donor), Application (Plasmapheresis, Plateletpheresis), Technology (Centrifuge, Membrane Separation) - Global Forecast to 2021The global apheresis market is estimated to reach USD 2.06 Billion by 2021, at a CAGR of 7.7% during the forecast period. The increasing demand for blood components and growing concerns regarding blood safety across the globe, rising prevalence of various blood disorders, increasing number of surgical procedures and emergency care cases in hospitals around the world are driving market growth. Extending reach of apheresis in the untapped pediatric segment and growth in emerging markets due to increasing investments presents significant growth opportunities for players in this market. However, high costs of apheresis machines & procedures and scarcity of qualified donors are the major restraining factors for this market. |
February 2017 | $ 5650 |
|
Pulmonary/ Respiratory Drug Delivery Market by Formulation (Type (Solution, Suspension, Dry powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End User (Hospitals, Homecare), Applications (COPD) - Forecasts to 2021The global pulmonary drug delivery market is projected to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016, at a CAGR of 6.5% during the forecast period. Growth in this market is mainly driven by increasing preference of pulmonary route as an alternate route of drug delivery, rising focus on the development of smart/digital inhalers and increasing incidence of respiratory diseases such as COPD, asthma, and cystic fibrosis. Emerging markets such as India, China, & Japan and growth in online marketing channels are expected to offer lucrative growth opportunities for market players in the coming years. On the other hand, factors such as regulatory issues and pricing pressures are the major factors restraining market growth. |
February 2017 | $ 5650 |
|
Professional Dental Care Market by Type (Toothbrush (Electric, Battery-powered), Toothpaste, Mouthwash, Denture Products, Dental Accessories (Whitening Products, Breath Freshener, Dental Floss, Dental Water Jet)) - Global Forecast to 2021The professional dental care market is expected to witness significant growth in the coming years. Factors such as the growing number of small/private dental clinics, rising incidences of dental caries, increasing disposable income in emerging countries, rising awareness about dental hygiene, an economic gain for dental practitioners are the major factors driving the growth of the global professional dental care market. The global professional dental care market is projected to USD 961.0 Million by 2021 from USD 769.3 Million in 2016, at a CAGR of 4.5% from 2016 to 2021. However, the rising trend of group/large dental practices and reluctance by dental practitioners towards the dental dispensing practices are expected to restrain the growth of this market to certain extent. |
February 2017 | $ 5650 |
|
Cold Plasma Market by Industry (Polymer, Textile, Electronics & Semiconductor, Food & Agriculture, Medical), Application (Coating, Adhesion, Finishing, Wound Healing, Decontamination), Regime (Atmospheric, Low-Pressure) - Global Forecast to 2021The cold plasma market witnessed healthy growth rate during the last decade and is expected to grow at a CAGR of 16.2% between 2016 and 2021 to reach USD 2.91 Billion by 2021. The growth in this market is mainly attributed to the benefits of cold plasma, such as its environment-friendliness; innovations in textile production; growing food safety concerns; innovations in cold plasma technology; and the increasing use of cold plasma in meat and poultry packaging decontamination |
February 2017 | $ 5650 |
|
Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables), End User (Hospital, Home Care), Indication - Global Forecast to 2021The global respiratory care devices market is projected to reach USD 24.07 Billion by 2021, at a CAGR of 9.7% from 2016 to 2021. The market growth can be attributed to a number of factors such as high prevalence of respiratory diseases, rapid growth in the aging population, the high prevalence of smoking, rising urbanization and pollution levels, increasing incidence of preterm births, and lifestyle changes. The rising demand for enhanced portable devices, growing demand for multimodal ventilators and focus of market players on expanding their geographic presence are the key trends of this market. However, the lack of awareness of respiratory conditions leading to a large underdiagnosed and undertreated population and the harmful effects of certain respiratory care devices on neonates are the major challenges in this market. |
February 2017 | $ 5650 |
|
Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel (Hospital), Patient Care Setting (Hospital, Home Care) - Forecast to 2021The global injectable drug delivery market, in terms of value, is projected to reach USD 624.50 Billion by 2021 from USD 362.38 Billion in 2016, at a CAGR of 11.5% during the forecast period. The injectable drug delivery market is segmented based on type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel, facility of use, and regions. |
February 2017 | $ 5650 |
|
Surgical Lasers Market by product type (Carbon Dioxide, Argon, Nd:YAG & Diode Lasers), Procedure (Open, Laparoscopic & Percutaneous), & Application (Ophthalmology, Urology, Gynaecology, Dermatology, Dental, Cardiology, & Oncology) - Global forecast to 2021The global surgical lasers market is projected to reach USD 2.37 Billion by 2021 from USD 1.85 Billion in 2016; growing at a CAGR of 5.1% during 2016-2021. The rising demand for surgical lasers can be attributed to the growing prevalence of chronic diseases, technological advancements, increasing incidence and prevalence of targeted diseases, and high prevalence of ophthalmic disorders. In addition, growing preference for minimally invasive surgeries among patients and healthcare professionals is supporting the growth of the surgical lasers market. |
February 2017 | $ 5650 |
|
Lung Cancer Surgery Market by Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy), Minimally Invasive), Device (Surgical (Clamps, Forceps, Retractors, Stapler), Monitoring (Camera, Trocar), Endoscopic Instrument) - Global Forecast to 2021The lung cancer surgery market is projected to reach USD 29.99 Billion by 2021 from USD 21.58 Billion in 2016, at a CAGR of 6.8% from 2016 to 2021. The major players in the lung cancer surgery market are Ethicon US LLC (U.S.), Intuitive Surgical Inc. (U.S.), Olympus Corporation (Japan), Accuray Inc. (U.S.), AngioDynamics Inc. (U.S.), Teleflex Inc. (U.S.), KARL STORZ GmbH (Germany), Ackermann Instrumente GmbH (Germany), Scanlan International Inc. (U.S.), and Trokamed GmbH (Germany). |
January 2017 | $ 5650 |
|
Surgical Microscopes Market by Application (Neuro and Spine Surgery, Plastic and Reconstructive Surgery, Ear, Nose, and Throat Surgery, Oncology, Urology, Documentations), End User (Hospitals, Outpatient Facility) - Global Forecast to 2021The global surgical/operating microscope market is projected to reach USD 915.6 Million by 2021 from USD 508.1 Million in 2016, growing at a CAGR of 12.5% during the forecast period. The increasing use of fluorescence image-guided surgery (FIGS), increase in the number of surgeries and growing demand for MIS, advancements in healthcare facilities, technological advancements, and customized microscopy solutions are the key factors driving the growth of the global surgical/operating microscopes market. |
January 2017 | $ 5650 |
|
U.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon), Orexin Antagonist) & OTC Treatment (Antihistamine, Melatonin, Valerian Root)) - Forecasts to 2021The U.S. insomnia market is categorised into pharmacological treatments and non-pharmacological treatments. The U.S. insomnia pharmacological treatment market is projected to reach USD 4.24 Billion by 2021 from USD 3.38 Billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021. The duration of insomnia can be from a day to years. Based on duration, insomnia is divided into three major categories, namely, transient insomnia (less than a month), short term insomnia (between 1 month and 6 months), and chronic insomnia (more than 6 months). |
January 2017 | $ 5650 |
|
U.S. Veterinary Infusion Pumps Market by Type (Large Volume Infusion Pumps, Syringe Infusion Pumps), End User (Private Hospitals, Private Clinics, Teaching Hospitals) - Forecast to 2021The U.S. veterinary infusion pumps market is expected to witness growth in the coming years as a result of the growing demand for pet insurance and increasing animal healthcare expenditure, rising demand for animal-derived food products, and growth in the number of veterinary practitioners and their income levels. This market is projected to reach USD 35.4 Million by 2021 from USD 26.6 Million in 2016, at a CAGR of 5.8% from 2016 to 2021. Growing adoption of companion animals and increasing prevalence of animal diseases requiring surgeries are the major factors that are expected to offer potential growth opportunities to market players. However, increasing pet care costs may hinder the growth of this market to a certain extent. |
January 2017 | $ 5650 |
|
CBCT/Cone Beam Imaging Market by Application (Dental (Oral and Maxillofacial Surgery, Implantology, Orthodontics, Endodontics), Patient Position (Standing/Sitting, Seated, Supine), End User (Hospital, Private Practice) - Global Forecast to 2021The global CBCT/Cone beam imaging market is expected to reach USD 801.2 Million by 2021 from USD 494.4 Million in 2016, at a CAGR of 10.1% during the forecast period (2016-2021). Factors such as increasing prevalence of dental disorders, growth in geriatric population, growing demand for cosmetic dentistry, and expanding applications of CBCT systems are expected to fuel growth in the CBCT systems market in the coming few years. |
January 2017 | $ 5650 |
|
Nasal Drug Delivery Technology Market by Dosage Form (Nasal Drops, Sprays, Powder, Gel), System (Multidose, Unit Dose, BI-Dose), Therapeutic Applications (Rhinitis, Congestion, Vaccinations), End User (Hospitals, Homecare) - Global Forecast to 2021The global nasal drug delivery technology market is projected to reach USD 64.20 Billion by 2021 from USD 44.00 Billion in 2016, at a CAGR of 6.5% during the forecast period. This market is segmented based on dosage form, therapeutic application, end user, system, container, and region. |
January 2017 | $ 5650 |
|
Interventional Radiology Products Market by type (Stents, Catheters, IVC Filter, Accessories), Procedure Type (Angioplasty, Angiography, Biopsy, Thrombolysis, Embolization), Applications (Oncology, Cardiology, Urology & Nephrology) - Forecast to 2021The global interventional radiology products market is expected to reach USD 8.02 Billion by 2021 from USD 6.35 Billion in 2016, at a CAGR of 4.8%. The major factors driving the growth of this market are rising incidence of chronic diseases, rising geriatric population, and increasing demand for minimally invasive surgeries. |
January 2017 | $ 5650 |
|
Electrosurgery Market by Product (Generators, Instruments-Bipolar (Vessel Sealing, Forceps) & Monopolar (Pencils, Electrodes), Accessories, Argon & Smoke Management Systems), Type of Surgery (Orthopedic, Cosmetic, Gynecology) - Global Forecast to 2021The global electrosurgery market is projected to reach USD 5.17 Billion by 2021, at a CAGR of 3.9% in the forecast period (2016–2021). Factors such as technological advancements in electrosurgery devices, growing number of medical, aesthetic and plastic surgeries, rising demand for minimally invasive surgeries, and growing number of ambulatory surgery centers are driving the growth of this market. On the other hand, healthcare reforms in the U.S., frequent product recalls, and risks associated with electrosurgical procedures are some of the key factors limiting the growth of the global electrosurgery market. |
January 2017 | $ 5650 |
|
Diagnostic Catheter Market by Type (Angiography, OCT, Ultrasound, Electrophysiology, Pressure and Hemodynamic Monitoring), Application Area (Cardiology, Urology, Neurology, Gastroenterology), End User (Hospitals, Imaging Centers) - Global Forecast to 2021The global diagnostic catheters market is projected to reach USD 4.30 Billion by 2021 from USD 3.02 Billion in 2016, at a CAGR of around 7.3% from 2016 to 2021. This market is mainly driven by the rising geriatric population, increasing prevalence of cardiovascular disorders, growing number of minimally invasive surgeries, growth in the number of diagnostic imaging centers, and technological advancements in imaging catheters. |
January 2017 | $ 5650 |
|
Nuclear Imaging Equipment Market by Product (SPECT (Hybrid SPECT, Standalone SPECT), Hybrid PET, Planar Scintigraphy), Application (Oncology, Cardiology & Neurology), End user (Hospitals, Imaging Centers) - Global Forecasts to 2021The nuclear imaging equipment market is projected to reach USD 2.85 Billion by 2021 from USD 2.25 Billion in 2016, growing at a CAGR of 4.8% during the forecast period, The major players in the global nuclear imaging equipment market are Siemens Healthineers (Germany), Philips Healthcare (Netherlands), and GE Healthcare (U.S.). The other players in the market include Toshiba Medical Systems Corporation (Japan), Neusoft Medical Systems Co., Ltd. (China), Mediso Medical Imaging Systems Ltd. (Hungary), Digirad Corporation (U.S.), CMR Naviscan Corporation (U.S.), SurgicEye GmbH (Germany), and DDD Diagnostics (Denmark). |
January 2017 | $ 5650 |
|
Blood Screening Market by Technology (Nucleic Acid Amplification, (rPCR), ELISA, (CLIA, Fluorescence assay), Rapid Test, NGS, Western Blotting), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital) - Global Forecasts to 2021The global blood screening market consists of various technologies and products & services which are used in blood banks and hospitals for the screening of various TTIs. The blood screening market is expected to reach USD 2.80 Billion by 2021 from USD 1.76 Billion in 2016, at a CAGR of 9.7%. The major factors driving the growth of this market are increasing number of blood donations and blood donors and rising awareness regarding the safety of donated blood. In addition, increasing affordability and adoption of nucleic acid test (NAT) for blood screening, rising demand for donated blood, and increasing prevalence of infectious diseases are also driving the growth of this market. |
January 2017 | $ 5650 |
|
Cardiovascular Ultrasound System Market by Test Type (Transesophageal, Stress, Transthoracic, Fetal), Technology (2D, 3D & 4D, Doppler Imaging), Device Display (Black & White, Color), End User (Hospitals, Home Care, Ambulatory) - Forecast to 2021The global cardiovascular ultrasound market is projected to reach USD 1.66 Billion by 2021 from USD 1.27 Billion in 2016, at a CAGR of 5.4% from 2016 to 2021. In this report, the global cardiovascular ultrasound system market is segmented on the basis of test type, technology, device display, end user, and region. Based on test type, the cardiovascular ultrasound system market is categorized into transthoracic echocardiogram, transesophageal echocardiogram, stress echocardiogram, and other echocardiograms. The other echocardiograms include fetal & intracardiac echocardiograms. |
December 2016 | $ 5650 |
|
Clinical Trial Imaging Market by Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-Ray), Product & Services (Software), End User (Pharmaceutical Companies, Biotechnology Companies, CROs, Medical Device Manufacturers) - Global Forecast to 2021The global market for clinical trial imaging is projected to reach $1069.7 million by 2021 from $773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021.In this report, the global clinical trial imaging market is broadly segmented by product and service, modality, end user, and region. Both, top-down and bottom-up approaches were used to validate the size of the global clinical trial imaging market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research and their market presence was studied through primary and secondary research. |
December 2016 | $ 5650 |
|
Fluid Management Systems Market by Product (Dialyzers, Insufflators, Fluid Warming systems, Pressure Transducers, Suction Canister), Disposables and Accessories, & Application (Urology, Laparoscopy, Gastroenterology, Gynecology) - Forecast to 2021The fluid management systems and accessories market is projected to reach USD 12.47 Billion by 2021 from USD 9.39 Billion in 2016, at a CAGR of 5.8% during the forecast period. Factors such as increasing number of minimally invasive surgeries, technological advancements in fluid management systems, and increase in government funds and grants worldwide for endosurgical procedures are driving the fluid management systems and accessories market. Moreover, the untapped potential in emerging markets and rising use of single-use disposable devices and accessories are expected to offer growth opportunities for players operating in the fluid management systems and accessories market. |
December 2016 | $ 5650 |
|
ECG Cable and ECG Lead wires Market by Material (Thermoplastic Elastomer, TPU), Usability (Reusable, Disposable), ECG Leadwires by Machine Type (3 lead, 5 lead), Patient Care Setting (Long term care facilities, Home care) - Forecast to 2021The ECG cable and ECG leadwires market is expected to witness significant growth in the coming years owing mainly to factors such as the rapidly increasing geriatric population, rising incidences of cardiovascular diseases and technological advancements. The global ECG cable and ECG leadwires market is projected to reach USD 1.75 Billion by 2021 from USD 1.32 Billion in 2016, at a CAGR of 5.7% from 2016 to 2021. However, factors such as high cost of the disposable cables and leadwires is limiting the growth of this market. |
November 2016 | $ 5650 |
|
Needle-Free Injection System Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) - Forecasts to 2021The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period. Growth in this market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices. |
November 2016 | $ 5650 |
|
Spinal Implants and Surgical Devices Market by Technology (Fusion, Fixation, VCF, Decompression, Motion Preservation), Product (Thoracic, Lumbar, Cervical, Interbody, Kyphoplasty, Artificial Discs, MIS, Biologics, Stimulators) - Global Forecast to 2021The global spinal implants and surgical devices market is estimated to reach 17.27 Billion by 2021, at a CAGR of 5.3% in during the forecast period. Technological advancements in spine surgery devices, and increasing aging and obese population with increasing number of spine deformities, and rising demand for minimally invasive spine surgery procedures are the key factors fueling the growth of the spinal implants and spinal devices market. Moreover, the emerging Asian and Latin American countries, growth in the number of hospitals and surgical centers, and commercial applications in high growth areas such as MIS, nucleus arthroplasty, artificial disc replacement, and stem cell technologies are expected to offer growth opportunities for players operating in the global spinal implants and surgical devices market. |
November 2016 | $ 5650 |
|
Women’s Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021The global women’s health diagnostics market is projected to reach USD 36.64 Billion by 2021 from USD 25.03 Billion in 2016, at a CAGR of around 7.9% during the forecast period. This market is mainly driven by the increased adoption of point-of-care & rapid diagnostic tests, growth in the number of private diagnostic centers, high prevalence of infectious diseases in women, rising incidence of chronic & lifestyle-related disorders in women and increasing awareness about fertility testing in women & initiatives taken by government and health organizations. |
November 2016 | $ 5650 |
|
Surgical Navigation Systems Market by Application (ENT, Orthopedic (Type (Imageless, Fluoroscopy, CT), Procedure (Knee, Hip)), Neuro, Spinal, Dental), Technology (EM, Hybrid, Optical), Patient Care Setting (Hospital, Clinic, Ambulatory) - Forecasts to 2021The global surgical navigation systems market is expected to reach USD 906.8 Million by 2021 from USD 662.5 Million in 2016, at a CAGR of 6.5% during the forecast period (2016–2021). Growth of this market is primarily driven by factors such as the rising adoption of minimally invasive surgical procedures; growing number of regulatory approvals, and partnerships, agreements, and collaborations among market players; increasing incidence of orthopedic and neurological disorders; and high prevalence of ENT disorders. However, the high cost of surgical navigation systems and product recalls are likely to create a negative impact on the growth of this market. |
November 2016 | $ 5650 |
|
Hemostasis/Coagulation Analyzer Market by Product (Clinical Laboratory & PoCT Analyzers), Consumables, Test (PT, Fibrinogen, APTT, ACT, D Dimer, Platelet Function), Technology (Mechanical, Optical, Electrochemical), End User (PoCT) - Forecast to 2021The coagulation analyzer market is projected to reach USD 4.84 Billion by 2021 from USD 2.98 Billion in 2016, at a CAGR of 10.2% from 2016 to 2021. On the basis of product, the coagulation analyzer market is segmented into clinical laboratory analyzers & PoC testing analyzers. The clinical laboratory analyzers segment is expected to account for the largest share of the global coagulation analyzers market in 2016, owing to increasing incidence of cardiovascular and blood related diseases. |
November 2016 | $ 5650 |
|
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.
Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement
Connect With Us
Live Chat Support
Search reports
Medical Devices ›
Information and Communications Technology ›
Semiconductor and Electronics ›
Chemicals ›
Advanced Materials ›
Energy and Power ›
Food and Beverage ›
Biotechnology ›
Aerospace and Defence ›
Healthcare IT ›
Automotive and Transportation ›
Automation and Process Control ›
Agriculture Industry ›
Packaging ›
Pharmaceuticals ›
Building and Construction ›
Mining, Minerals and Metals ›
Analytical and Scientific Instrumentation ›
Engineering Equipment and Devices ›
'Connect With Us
